Excellence is just the beginning.


French German Italian Portuguese Russian

Parkinson’s Disease and Movement Disorders Program — Clinical Trials

Huntington's Disease Cohort Prospective Registry Study

ENROLL-HD: A prospective registry study in a global Huntington’s disease cohort

INSIGHTS Study: Investigational Drug Treatment for Patients with Advanced Parkinson's Disease

INSIGHTS study: An open-label, randomized 26-week study comparing levodopa-carbidopa INteStInal gel (LCIG) THerapy to optimized medical treatment (OMT) on non-motor symptoms (NMS) in subjects with advanced Parkinson's disease.

KICK OUT 2: Study of a Karate Intervention to Change Kinematic Outcomes in Parkinson’s Disease

KICK OUT 2: A phase two, randomized, waitlist-controlled trial of a Karate Intervention to Change Kinematic OUTcomes in Parkinson’s disease.

Parkinson’s Disease Psychosis Treatment Study

A randomized, parallel-group, multicenter study to evaluate the efficacy, safety, and tolerability of SEP 363856 in subjects with Parkinson’s disease psychosis.

Study of Diet-Microbiome Interactions and Parkinson’s Disease

Diet-microbiome interactions and Parkinson’s disease.

Study to Determine the Changes in Cognition in Patients with Parkinson’s Disease

Study to identify genetic forms of Parkinson’s disease and determine how cognition changes in these subjects.

Treatment of Postural and Gait Dysfunction in Parkinson's Disease

Varenicline (Chantix) for the treatment of postural and gait dysfunction in Parkinson's disease

Treatment Study for Patients with Neurogenic Orthostatic Hypotension

A clinical study of patients with symptomatic neurogenic orthostatic hypotension to assess sustained effects of droxidopa therapy (RESTORE).